Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period

Transplantation Proceedings

Volumn 36, Issue 9, 2004, Pages 2675-2678

  Formica Jr , R N ^a   Friedman, A L ^a   Lorber, M I ^a   Bia, M J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN; POTASSIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; POTASSIUM; RECEPTOR, ANGIOTENSIN, TYPE 2; RETROSPECTIVE STUDIES; SAFETY; TRANSPLANTATION, HOMOLOGOUS;

EID: 11144257066     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.10.013     Document Type: Article

References (17)

1. G. Remuzzi, N. Perico Routine renin-angiotensin system blockade in renal transplantation? Curr Opin Nephrol Hypertens 11 2002 1
2. J.D. Neaton, R.H. Grimm Jr, R.J. Prineas Treatment of Mild Hypertension Study Final results. Treatment of Mild Hypertension Study Research Group JAMA 270 1993 713
3. E.J. Lewis, L.G. Hunsicker, R.P. Bain The effect of angiotensin- converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 1993 1456
4. M. Ravid, D. Brosh, Z. Levi Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus A randomized, controlled trial Ann Intern Med 128 1998 982
5. G. Maschio, D. Alberti, G. Janin Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group N Engl J Med 334 1996 939
6. T.H. Jafar, C.H. Schmid, M. Landa Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease A meta-analysis of patient-level data Ann Intern Med 135 2001 73
7. B.M. Brenner, M.E. Cooper, D. de Zeeuw Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 2001 861
8. E.J. Lewis, L.G. Hunsicker, W.R. Clarke Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes N Engl J Med 345 2001 851
9. H.H. Parving, H. Lehnert, J. Brochner-Mortensen The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes N Engl J Med 345 2001 870
10. J. Calvino, X.M. Lens, R. Romero Long-term anti-proteinuric effect of losartan in renal transplant recipients treated for hypertension Nephrol Dial Transplant 15 2000 82
11. A. Martinez-Castelao, M. Hueso, V. Sanz Treatment of hypertension after renal transplantation: long-term efficacy of verapamil, enalapril, and doxazosin Kidney Int Suppl 68 1998 S130
12. A. Schmidt, U. Gruber, G. Bohmig The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA Nephrol Dial Transplant 16 2001 1034
13. C.E. Stigant, J. Cohen, M. Vivera ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy Am J Kidney Dis 35 2000 58
14. K. Midtvedt, A. Hartmann, A. Foss Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril Transplantation 72 2001 1787
15. D.W. Cockcroft, M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31
16. J.D. Robinson, S.M. Lupkiewicz, L. Palenik Determination of ideal body weight for drug dosage calculations Am J Hosp Pharm 40 1983 1016
17. K. Midtvedt, A. Hatmann, A. Foss Sustained improvement of renal graft function for two years in hypertensive renal transplant recipients treated with nifedipine as compared to lisinopril Transplantation 72 2001 1787